Sign up to save your podcasts
Or
Share JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint–Based Therapy in Patients With Advanced NSCLC
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
More shows like JAMA Network
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
320 Listeners
AFP: American Family Physician Podcast
699 Listeners
JAMA Clinical Reviews
497 Listeners
Medicine and Science from The BMJ
36 Listeners
Diabetes Core Update
103 Listeners
Mayo Clinic Talks
292 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
19 Listeners
JAMA Otolaryngology–Head & Neck Surgery Author Interviews
7 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Cardionerds: A Cardiology Podcast
425 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
The Curious Clinicians
374 Listeners
NEJM AI Grand Rounds
61 Listeners